In November 2017, the Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017 American College of Cardiology [ACC]/American Heart Association [AHA] hypertension [HTN] guideline) was published. This new national HTN guideline supersedes various guidelines (except some comorbidity-specific guidelines) that were previously used in practice since the last national guideline was released in 2003.
At the completion of this activity, the pharmacist will be able to:
1. Address the Identify and manage (if applicable) modifiable and relatively fixed CVD risk factors and secondary causes of HTN.
2. Apply appropriate BP measurement technique and utilize out-of-office BP monitoring methods for the diagnosis and management of hypertension.
3. Set appropriate blood pressure treatment threshold and goals for patients according to their 10-year atherosclerotic cardiovascular disease (ASCVD) risk and concomitant conditions.
4. Develop an optimal non-pharmacologic and pharmacologic treatment plan for a patient with hypertension (HTN) according to practice guidelines and clinical trial evidence.
5. Select appropriate medications for the treatment of HTN according to comorbid conditions and resistant HTN.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-145-H04-P.
To obtain credit for "The 2017 ACC/AHA Guidelines for Blood Pressure Management in Adult Patients," complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
Initial release date: April 1, 2018
Expiration date: April1, 2021 - NO CREDIT GRANTED AFTER THIS DATE
"The 2017 ACC/AHA Guidelines for Blood Pressure Management in Adult Patients” is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.
Karen J. McConnell, PharmD, FCCP, BCPS-AQ, Cardiology, ASHCHC, System Director of Clinical Pharmacy Services, National Clinical Enterprise, Catholic Health Initiatives, Englewood, CO
Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, FCCP, FASHP, FNLA, professor and vice chair, departments of clinical pharmacy and family medicine, University of Colorado Anschutz Campus Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver
Karen J. McConnell, PharmD, FCCP, BCPS-AQ Cardiology, ASH-CHC; Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, FCCP, FASHP, FNLA; and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and internet access are required to complete this activity. Please visit our website and view the Technology System Requirements to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-18-145-H04-P||0.2 CEUs||April 01, 2018 - April 01, 2021|